Voss Capital LP Makes New Investment in Iovance Biotherapeutics, Inc. $IOVA
Voss Capital LP purchased a new stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 672,570 shares of the biotechnology company’s stock, valued at approximately $1,157,000. Several other institutional investors also recently made changes to their […]
8 Dec 08:08 · The Cerbat Gem